Abstract
CCND1 alternation is common in HPV(-) HNSCC patients. In in vitro and animal study, CDK 4/6 inhibitors can increase T cell function and increase HLA expression in tumor microenvironment. We hypothesized that adding CDK4/6 inhibitors can augment the efficacy of anti-PD1 in HNSCC patients.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
